This isn’t what I was looking for. Don’t worry though, this was a hard question!
The key to thinking about this is understanding that a patient would likely be treated with multiple different classes of chemotherapeutic to target different aspects of tumour cell behaviour. So, think about what hallmark of cancer would make them resistant to multiple classes of drug.
LaNts and Laminins 